Global Antiplatelet Drugs Market: Overview

Globally, the number of people suffering from ischemic strokes has increased, especially in developed countries. People suffering from myocardial infarction and stent thrombosis have also gone up. The use of antiplatelet drugs helps in reducing the ability of platelets to stick together and obstructs blood clots formation that leads to these diseases. Thus, its demand has grown significantly in the past few years.

Advancement in pharmaceuticals, proliferation of anticoagulant/antithrombotic drugs, and rising thrombolytic events are the key drivers for the antiplatelet drugs market. Antiplatelet drugs help in effective arterial circulation and are widely used in the primary and secondary prevention of cardiovascular or thrombotic cerebrovascular disorders.

The global antiplatelet drugs market could be classified on the basis of disease type, drug class, and distribution channel. Based on distribution channel, the market is segmented into online pharmacies, retail pharmacies, and hospital pharmacies. Based on drug class, the market is segmented into platelet aggregation inhibitors, glycoprotein platelet inhibitors, and protease-activated receptor-1 antagonists.

The report provides a detailed description of the global antiplatelet drugs market. It provides information focusing on the drivers, restraints, trends, and opportunities affecting the growth of the market. Furthermore, regional analysis with key segment analysis derived through facts and figures is also presented in the report.  

Global Antiplatelet Drugs Market: Trends and Opportunities

According to the data provided by the American Heart Association, there are about 800,000 individuals suffer from stroke every year in the U.S. among these three out of four-experience stroke the very first time. Of these, 87% are ischemic strokes. Moreover, based on the data provided by the Centers for Disease Control and Prevention, 735,000 people have a heart attack in Latin America and North America. Of these 525,000 people experience heart attack the very first time. Thus, the growing trend of these diseases has led to the growth of the antiplatelet drugs market.  

Global Antiplatelet Drugs Market: Geographic Analysis

Regions taken into consideration while analyzing the growth of the antiplatelet drugs market are Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. Among these regions, in 2016, North America held the larger share in the market. A large number of patients suffering from myocardial infarction led to the dominance of this region. In the same year, Europe held the second position in the market due to the rise in research and development on antiplatelet drugs. On the other hand, Asia Pacific market is expected to grow at a significate rate owing to rising government initiatives to reduce the number of deaths caused by stent thrombosis, ischemic stroke, and myocardial infarction.

Global Antiplatelet Drugs Market: Competitive Landscape

The competitive landscape given in the report on the global antiplatelet drugs market provides detail description about the prominent players operating in the market. Leading players in the market are implementing advanced business development strategies to get a strong hold in the global market. Sanofi, Otsuka Pharmaceutical Company, Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., AstraZeneca, and Boehringer Ingelheim GmbH are some of the prominent players operating in the market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Antiplatelet Drugs Market

Pre Book